 |
 Play Video: The Importance of Insider Buying
|
|
|
| Date | Insider | Price | Amount |
|---|
3-22-2024
Insider Buy |
Mallory Morales
Chief Accounting Officer |
$2.67
CAGR »
|
$4,009.10
1,500 shares |
3-22-2024
Insider Buy |
Harold Eugene Brakewood
Chief Business Officer |
$2.57
CAGR »
|
$10,015.20
3,900 shares |
3-22-2024
Insider Buy |
Peter Feinberg
Director |
$2.55
CAGR »
|
$63,712.50
25,000 shares |
3-20-2024
Insider Buy |
Brett Matthew Hall
CHIEF SCIENTIFIC OFFICER |
$2.86
CAGR »
|
$20,020.00
7,000 shares |
3-20-2024
Insider Buy |
Leah R. Neufeld
CHIEF PEOPLE OFFICER |
$2.88
CAGR »
|
$10,993.17
3,818 shares |
5-17-2022
Insider Buy |
Michael Bookman
GENERAL COUNSEL AND SECRETARY |
$4.88
CAGR »
|
$4,880.00
1,000 shares |
5-12-2022
Insider Buy |
Biren Amin
CFO, TREASURER |
$4.42
CAGR »
|
$4,420.00
1,000 shares |
3-23-2022
Insider Buy |
Benjamin J. Zeskind
PRESIDENT AND CEO |
$8.02
CAGR »
|
$24,060.00
3,000 shares |
3-23-2022
Insider Buy |
Brett Matthew Hall
CHIEF SCIENTIFIC OFFICER |
$7.91
CAGR »
|
$8,305.50
1,050 shares |
3-22-2022
Insider Buy |
Scott Barrett
CHIEF MEDICAL OFFICER |
$7.49
CAGR »
|
$6,736.50
900 shares |
3-15-2022
Insider Buy |
Peter Feinberg
|
$6.75
CAGR »
|
$45,002.25
6,667 shares |
9-20-2021
Insider Buy |
Peter Feinberg
|
$24.45
CAGR »
|
$116,113.75
4,750 shares |
9-13-2021
Insider Buy |
Benjamin J. Zeskind
PRESIDENT AND CEO |
$22.87
CAGR »
|
$47,631.96
2,083 shares |
8-3-2021
Insider Buy |
Asset Management, LP Cormorant
|
$15.00
CAGR »
|
$8,250,000.00
550,000 shares |
9-13-2021
Insider Buy |
Peter Feinberg
|
$21.50
CAGR »
|
$131,113.70
6,099 shares |
8-3-2021
Insider Buy |
Biren Amin
CFO, Treasurer |
$15.00
CAGR »
|
$62,625.00
4,175 shares |
8-3-2021
Insider Buy |
Scott Barrett
Chief Medical Officer |
$15.00
CAGR »
|
$10,005.00
667 shares |
8-3-2021
Insider Buy |
Ann E. Berman
Director |
$15.00
CAGR »
|
$52,500.00
3,500 shares |
8-3-2021
Insider Buy |
Michael Bookman
General Counsel and Secretary |
$15.00
CAGR »
|
$21,030.00
1,402 shares |
8-3-2021
Insider Buy |
Robert J. Carpenter
Director |
$15.00
CAGR »
|
$4,875,000.00
325,000 shares |
8-3-2021
Insider Buy |
Brett Matthew Hall
Chief Scientific Officer |
$15.00
CAGR »
|
$20,295.00
1,353 shares |
8-3-2021
Insider Buy |
Laurie Keating
Director |
$15.00
CAGR »
|
$105,000.00
7,000 shares |
8-3-2021
Insider Buy |
Benjamin J. Zeskind
President and CEO |
$15.00
CAGR »
|
$31,470.00
2,098 shares |
8-3-2021
Insider Buy |
Peter Feinberg
Director |
$15.00
CAGR »
|
$4,375,005.00
291,667 shares |
Also See: Institutional Holders of IMRX
Also See: SEC filings
Below we present the annualized performance delivered by IMRX stock since 3-22-2024 (the date of the most recent
insider purchase). The performance of the investment from the time IMRX insider buying occurred is the ultimate
test of whether insiders were right about IMRX being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
03/25/2024 |
|
| End date: |
04/26/2024 |
|
| Start price/share: |
$2.53 |
|
| End price/share: |
$1.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-41.90% |
|
| Annualized Gain: |
-477.89% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$5,810.00 |
|
| Years: |
0.09 |
|
IMRX Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent IMRX insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding IMRX
|
|
Free IMRX Email Alerts:
